Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > U.S. Cannabis Testing Market

U.S. Cannabis Testing Market Share

Report ID: GMI4481
Published Date: Oct 2022
Report Format: PDF

Download Free Sample

U.S. Cannabis Testing Market Share

Anresco
SC Labs, Inc
CW Analytical Laboratories
Digipath, Inc
EVIO, Inc
Eurofins Scientific
Pure Analytics LLC
PSI Labs
Green Scientific Labs
Steep Hills, Inc

are some of the key U.S. cannabis testing market players. These companies are majorly engaging in organic collaborations and partnerships with private and public firms to expand their customer reach, thereby influencing the overall business scenario.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The U.S. market size for cannabis testing was valued at more than USD 1.5 billion in 2021 and is set to progress at around 10.5% CAGR between 2022 and 2030 owing to rigorous R&D initiatives to utilize cannabis for treating infections and illnesses.

The residual solvent screening segment is projected to capture nearly 14% market share by 2030 on account of increasing awareness regarding its importance in the analysis of highly concentrated forms of cannabis.

U.S. cannabis testing market from spectroscopy segment is poised to be valued at USD 1.2 billion by 2030 as the technology provides real-time analysis, high throughput, and minimal requirements for sample preparation.

The Pacific Central cannabis testing industry is speculated to grow at more than 10.5% CAGR over 2022-2030 as a result of favorable regulatory norms pertaining to cannabis testing and substantial demand for medical marijuana in the states.